Meta-analysis · 2025
Efficacy and safety of botulinum toxin-A injection in the treatment of premature ejaculation: A systematic review and meta-analysis
Guo Y, Sun F, Wang Y, Li Y, Wang T, Ma X, Wu J (2025). Efficacy and safety of botulinum toxin-A injection in the treatment of premature ejaculation: A systematic review and meta-analysis. PLoS One. doi:10.1371/journal.pone.0315470
Pooling three placebo-controlled trials, botulinum toxin-A lengthened latency by about 22 seconds at one month, but the difference disappeared by three and six months, sexual satisfaction did not improve and adverse events were more common.
Summary
The authors searched PubMed, Embase and Cochrane for randomised controlled trials comparing botulinum toxin-A injection with placebo for premature ejaculation (PE), using a random-effects model.
Three studies were included. At one month, botulinum toxin-A increased intravaginal ejaculatory latency time (IELT) by a mean of 22.32 seconds and improved Premature Ejaculation Profile scores, but there were no significant differences at three and six months. Sexual satisfaction did not improve. Adverse events were more frequent than with placebo (odds ratio 5.90), although dribbling and erectile dysfunction were not significantly more common.
Limitations
Only three trials were available, and follow-up was short. The authors call for larger studies with longer follow-up.
What it means for you
Even in the more favourable analysis, the benefit was about 20 seconds and lasted roughly a month. That is a small, temporary effect for an injection with more side effects than placebo.